Short-term morbidity following primary closure, skin grafting and flap reconstruction after surgical resection of extremity soft-tissue sarcomas: Pushing the limits of limb preservation
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.109705 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von J D Generaal und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Groningen, University Medical Center Groningen, Department of Surgery, Division of Surgical Oncology, Hanzeplein 1, 9713 GZ, Groningen,…. Hauptthemen laut MEDLINE: Sarcoma, Skin Transplantation, Surgical Flaps, Plastic Surgery Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Understanding short-term morbidity following extremity soft-tissue sarcoma (ESTS) treatment remains complex due to diverse findings and the absence of a standardized wound complication assessment. This retrospective cohort study evaluated short-term morbidity following primary closure, skin grafting, and flap reconstruction. MATERIALS AND METHODS: All ESTS patients treated in a sarcoma center in the Netherlands from 1-1-2010 until 1-8-2022 were included. Short-term morbidity, defined as a wound complication following surgery, was assessed by the Toronto Sarcoma Flap Score (TSFS). The TSFS is an ordinal scale, where 0 indicates the absence of complications, while 10 signifies reconstructive failure necessitating amputation. Hospital stay duration and readmission rates were also analyzed. RESULTS: Limb preservation was achieved in 128 (97.7 %) of 131 patients. Wound complications occurred in 43 (44.3 %) of patients with primary closure, 8 (57.1 %) with skin grafting and 16 (80.0 %) with flap reconstruction, p = 0.01. Patients undergoing flap reconstructions had higher TSFSs (6 [IQR 7], versus 0 [IQR 3] for primary closure and 3 [IQR 6] for skin grafting), longer duration of hospital stays (14 [IQR 18] days versus 4 [IQR 3] days for primary closure and 5 [IQR 7] days for skin grafting, p < 0.01) and were more frequently readmitted (40.0 %, versus 17.5 % for primary closure and 21.4 % for skin grafting, p = 0.09). CONCLUSION: High limb preservation rates were achieved. Reconstructive surgery allows for the closure of extensive soft-tissue defects following ESTS resection, but it adds to surgical complexity. Patients undergoing flap reconstruction seem to be at a higher risk of short-term morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Groningen, University Medical Center Groningen, Department of Surgery, Division of Surgical Oncology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands. Electronic address: j.d.generaal@umcg.nl.
- Ommelander Hospital Groningen, Department of Surgery, Pastorieweg 1, 9679 BJ, Scheemda, the Netherlands.
- University of Groningen, University Medical Center Groningen, Department of Surgery, Division of Surgical Oncology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.
Zitieren
APA
Generaal, J. D., Bosscher, M. R. F., Been, L. B., & van Leeuwen, B. L. (2025). Short-term morbidity following primary closure, skin grafting and flap reconstruction after surgical resection of extremity soft-tissue sarcomas: Pushing the limits of limb preservation. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.109705
Vancouver
Generaal JD, Bosscher MRF, Been LB, van Leeuwen BL. Short-term morbidity following primary closure, skin grafting and flap reconstruction after surgical resection of extremity soft-tissue sarcomas: Pushing the limits of limb preservation. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.109705
BibTeX
@article{Generaal2025,
author = {Generaal, J D and Bosscher, M R F and Been, L B and van Leeuwen, B L},
title = {Short-term morbidity following primary closure, skin grafting and flap reconstruction after surgical resection of extremity soft-tissue sarcomas: Pushing the limits of limb preservation},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.109705}
}
EUVIMED